Latest operating income for MTP: $-16M.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025
Midatech Pharma Plc (MTP) currently reports a operating income of $-16M as of December 2025. That compares with $-6.6M in the prior-year period — down 140.1% year over year. Use the charts on this page to explore Midatech Pharma Plc's operating income history and peer comparisons.
Midatech Pharma Plc's operating income decreased from $-6.6M to $-16M — a 140.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Midatech Pharma Plc reported $-16M in operating income as of December 2025. That compares with $-6.6M in the prior-year period — down 140.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current operating income of $-16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Midatech Pharma Plc, and consider following MTP for alerts when major investors trade the stock.
Midatech Pharma Plc is classified in the Healthcare sector. On operating income, it currently shows $-16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MTP with unrelated industries.